Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome
Clinical trial NCT04402580 · TERMINATED
Trial details
- NCT number
- NCT04402580
- Sponsor
- Istituto Giannina Gaslini
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2020-08-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.